Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Cozzi Lepri

Showing results (51-60 of 58) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 58 results.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 21, 2001
Increasing prevalence of non-clade B HIV-1 strains in heterosexual men and women, as monitored by analysis of reverse transcriptase and protease sequencesC Balotta, G Facchi, M Violin, et al.
HIV Medicine|October 7, 2017
Incidence of cancer and overall risk of mortality in individuals treated with raltegravir-based and non-raltegravir-based combination antiretroviral therapy regimensA Cozzi-Lepri, R Zangerle, L Machala, et al.
Journal of Biological Regulators and Homeostatic Agents|May 11, 2002
Primary HIV-1 resistance in recently and chronically infected individuals of the Italian Cohort Naive for AntiretroviralsM Violin, F Forbici, A Cozzi-Lepri, et al.
HIV Medicine|February 2, 2018
Long-term effectiveness of recommended boosted protease inhibitor-based antiretroviral therapy in EuropeJ R Santos, A Cozzi-Lepri, A Phillips, et al.
The Journal of Infectious Diseases|September 28, 2001
Secondary mutations in the protease region of human immunodeficiency virus and virologic failure in drug-naive patients treated with protease inhibitor-based therapyC F Perno, A Cozzi-Lepri, C Balotta, et al.
HIV Medicine|January 15, 2015
Efficacy of etravirine combined with darunavir or other ritonavir-boosted protease inhibitors in HIV-1-infected patients: an observational study using pooled European cohort dataJ Vingerhoets, V Calvez, P Flandre, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|October 21, 2015
Contribution of APOBEC3G/F activity to the development of low-abundance drug-resistant human immunodeficiency virus type 1 variantsM Noguera-Julian, A Cozzi-Lepri, F Di Giallonardo, et al.
HIV Medicine|September 15, 2016
Higher rates of triple-class virological failure in perinatally HIV-infected teenagers compared with heterosexually infected young adults in EuropeA Judd, R Lodwick, A Noguera-Julian, et al.
Pageof 6

Showing results (51-60 of 58) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 58 results.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 21, 2001
Increasing prevalence of non-clade B HIV-1 strains in heterosexual men and women, as monitored by analysis of reverse transcriptase and protease sequencesC Balotta, G Facchi, M Violin, et al.
HIV Medicine|October 7, 2017
Incidence of cancer and overall risk of mortality in individuals treated with raltegravir-based and non-raltegravir-based combination antiretroviral therapy regimensA Cozzi-Lepri, R Zangerle, L Machala, et al.
Journal of Biological Regulators and Homeostatic Agents|May 11, 2002
Primary HIV-1 resistance in recently and chronically infected individuals of the Italian Cohort Naive for AntiretroviralsM Violin, F Forbici, A Cozzi-Lepri, et al.
HIV Medicine|February 2, 2018
Long-term effectiveness of recommended boosted protease inhibitor-based antiretroviral therapy in EuropeJ R Santos, A Cozzi-Lepri, A Phillips, et al.
The Journal of Infectious Diseases|September 28, 2001
Secondary mutations in the protease region of human immunodeficiency virus and virologic failure in drug-naive patients treated with protease inhibitor-based therapyC F Perno, A Cozzi-Lepri, C Balotta, et al.
HIV Medicine|January 15, 2015
Efficacy of etravirine combined with darunavir or other ritonavir-boosted protease inhibitors in HIV-1-infected patients: an observational study using pooled European cohort dataJ Vingerhoets, V Calvez, P Flandre, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|October 21, 2015
Contribution of APOBEC3G/F activity to the development of low-abundance drug-resistant human immunodeficiency virus type 1 variantsM Noguera-Julian, A Cozzi-Lepri, F Di Giallonardo, et al.
HIV Medicine|September 15, 2016
Higher rates of triple-class virological failure in perinatally HIV-infected teenagers compared with heterosexually infected young adults in EuropeA Judd, R Lodwick, A Noguera-Julian, et al.
Pageof 6